AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Raghudic-AQ Injection

Prescription Icon
Prescription Required

Marketer

Godrams Lifeline

Salt Composition

Diclofenac (75mg)

Overview Raghudic-AQ Injection

Aqueos-R injection offers analgesia, effectively managing pain, inflammation, and joint stiffness associated with conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral routes are unsuitable. This injectable medication must be administered by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, erythema) to your doctor immediately. Commonly reported adverse effects include nausea, emesis, cephalgia, and local injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, and hematological parameters. Chronic use carries a risk of significant complications including gastrointestinal hemorrhage and nephropathy.

Uses of Raghudic-AQ Injection

Alleviation of discomfort

Major Benefits of Raghudic-AQ Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.

Common Side effects of Raghudic-AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Raghudic-AQ Injection:

The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

How Raghudic-AQ Injection works:

Raghudic-AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and the associated symptoms of redness and swelling.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when drinking alcohol while receiving Raghudic-AQ Injection. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Raghudic-AQ Injection during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Raghudic-AQ Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Administration of Raghudic-AQ Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Exercise caution when administering Raghudic-AQ Injection to individuals with impaired renal function. Dosage modification for Raghudic-AQ Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

For individuals with hepatic impairment, administering Raghudic-AQ Injection requires careful consideration. Dosage modification of Raghudic-AQ Injection might be necessary. Physician consultation is advised.

What if you forget to take Raghudic-AQ Injection :

Omit a Raghudic-AQ Injection dose? Seek your physician's advice.

Facts to Know About Raghudic-AQ Injection

LabelValue
Chemical Type Phenylacetic acid derivative
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Raghudic-AQ Injection

Raghudic-AQ Injection must be administered only by a healthcare professional. Injection routes include intramuscular (preferably in the buttock), subcutaneous, or intravenous bolus administration; infusion is not permitted. The prescribed dose should not be exceeded, and treatment should not last longer than two days.
Raghudic-AQ Injection may raise your risk of heart attack or stroke, particularly with higher doses or prolonged use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially fatal and without warning at any time. Seek immediate medical attention if you experience such symptoms.
Raghudic-AQ Injection provides effective pain and inflammation relief. Its applications include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Raghudic-AQ Injection, when used long-term or in high doses, can potentially lead to kidney issues like blood or protein in the urine and painful urination. Individuals at heightened risk—including those dehydrated, with heart failure, impaired kidney function, hypertension, or who are elderly—or those taking diuretics or other nephrotoxic medications, should have their kidney function monitored.
Raghudic-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon. Avoid driving or operating machinery if you experience any of these symptoms.
Avoid Raghudic-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature labor. Its use should also be avoided during the first six months. Prescription during pregnancy should only occur when benefits clearly outweigh risks. Consult your doctor before using Raghudic-AQ Injection if you are pregnant.
Raghudic-AQ Injection is not a recreational drug; it has no potential for abuse or dependence. If you experience any adverse effects, seek medical advice.
Raghudic-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Raghudic-AQ Injection
13
MRP 15
13% off